Related Experiment Video
Updated: Jul 14, 2026
04:41
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Association of integrin alpha2 gene variants with ischemic stroke
Mar Matarin1, W Mark Brown, John A Hardy
1Neurogenetics Laboratory, National Institute on Aging, Bethesda, Maryland, USA.
Summary
Genetic variations in the integrin alpha2 (ITGA2) gene are linked to increased ischemic stroke risk. This study found specific ITGA2 single-nucleotide polymorphisms (tSNPs) associated with higher stroke risk in North American populations.
Area of Science:
- Genetics
- Neurology
- Cardiovascular Research
Background:
- Genetic variants in the integrin alpha2 (ITGA2) gene have been previously associated with an elevated risk of ischemic stroke.
- Integrin alpha2 plays a crucial role in platelet aggregation and vascular cell adhesion, suggesting a potential mechanism in stroke pathogenesis.
Purpose of the Study:
- To investigate the association between haplotype-tagging single-nucleotide polymorphisms (tSNPs) in the ITGA2 gene and the risk of ischemic stroke.
- To analyze these associations in a North American cohort of stroke cases and controls.
Main Methods:
- Genotyping of thirteen haplotype-tagging single-nucleotide polymorphisms (tSNPs) in the ITGA2 gene.
- Association tests were performed for individual tSNPs and across all tSNPs, including haplotype association analysis.
- Secondary analyses examined stroke subtypes using Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria.
Main Results:
- A significant association was observed between tSNP rs3756541 (OR, 1.49; P=0.009) and ischemic stroke risk.
- A trend toward association was noted for tSNP rs2303124 (OR, 1.56; P=0.03).
- These associations remained significant in haplotype analyses and did not differentiate stroke etiology based on TOAST criteria.
Conclusions:
- Genetic variability within the ITGA2 gene is suggested to confer risk for ischemic stroke, potentially independent of conventional risk factors.
- These findings support the role of platelet receptor genes, such as ITGA2, in the pathogenesis of various ischemic stroke subtypes.
Related Concept Videos
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...